Magnetic resonance spectroscopy in human cardiomyopathies

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Magnetic resonance spectroscopy (MRS) can noninvasively provide a window into the metabolic status of the heart. This technique has shown abnormalities in the phosphocreatine-to-adenosine triphosphate ratio in patients with severe cardiomyopathies, either dilated or hypertrophic. Data indicate that abnormal metabolic parameters can risk stratify patients with dilated cardiomyopathy and provide independent prognostic information. Finally, the use of MRS in patients after cardiac transplantation is being explored. The information from cardiac MRS will likely provide the investigator and clinician with unique data and assist in the diagnosis and management of patients with various forms of heart disease.

Original languageEnglish (US)
Pages (from-to)151-157
Number of pages7
JournalJournal of Cardiovascular Magnetic Resonance
Issue number2
StatePublished - 2000


  • Cardiomyopathy
  • Hypertrophy
  • Phosphorus-31 spectroscopy
  • Transplantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Family Practice


Dive into the research topics of 'Magnetic resonance spectroscopy in human cardiomyopathies'. Together they form a unique fingerprint.

Cite this